Relaxation and Meditation Techniques on Pain, Fatigue and Quality of Life
Progressive Muscle Relaxation and Mindfulness Meditation on Neuropathic Pain, Fatigue and Quality of Life in Type 2 Diabetes Patients: A Randomized Clinical Trial
1 other identifier
interventional
77
1 country
1
Brief Summary
Patients with painful diabethic peripheral neuropathy will be entered.. Participants will be randomized to one of three study arms: Arm 1: relaxatio; Arm 2:meditation Arm 3: Attention matched control Hypothesis: Progressive muscle relaxation and mindfullness meditation will decrease severity of neuropathc pain and fatigue and improve quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2019
CompletedFirst Submitted
Initial submission to the registry
February 24, 2020
CompletedFirst Posted
Study publicly available on registry
February 27, 2020
CompletedFebruary 27, 2020
February 1, 2020
1.4 years
February 24, 2020
February 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain severity
Pain severity will be measured based on patient report by a visual analog scale. Higher score means increase in pain severity.
Baseline measurements, at the end of 12th week and two weeks after the completion of the interventions
Secondary Outcomes (2)
Change in fatigue severity
Baseline measurements, at the end of 12th week and two weeks after the completion of the interventions
Change in Quality of life status
baseline measurements, at the end of 12th week and two weeks after the completion of the interventions
Study Arms (3)
Relaxation
EXPERIMENTALPatients will receive a training session for progressive muscle relaxation exercise. They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.
Meditation
EXPERIMENTALPatients will receive a training session for minfullness meditation They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.
Attention matched control group
ACTIVE COMPARATORPatients will receive a training session focusing on the anatomy and physiological functions of the pancreas, general information about type 2 diabetes including signs, complication, and treatment methods.
Interventions
Patients will receive a training session for progressive muscle relaxation exercise They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.
Patients will receive a training session for mindfulness meditation. They will practice it daily at their home during 12 weeks. Patients will be called daily to ensure that patients perform the intervention according to the study protocol, and to assess their study-adherence.
Patients will receive a training session focusing on focusing on the anatomy and physiological functions of the pancreas, general information about type 2 diabetes including signs, complication, and treatment methods
Eligibility Criteria
You may qualify if:
- being diagnosed with painful diabethic peripheral neuropathy ,
- being at least primary school graduates,
- not using any other complementary or integrative therapy during the study period
You may not qualify if:
- neuropathy history due to any other causes such as megaloblastic anemia, fibromyalgia, autoimmune diseases, hypothyroidism, and lumbar disc hernia
- having end-stage of renal failure, chronic obstructive pulmonary disease, advanced cardiac failure, musculoskeletal disorders or depression
- having a diabetic foot ulcer or amputation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University Medical Faculty Ibni Sina Hospital Endocrinology Outpatient Unit
Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nur Izgu, PhD
Hacettepe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
February 24, 2020
First Posted
February 27, 2020
Study Start
June 8, 2018
Primary Completion
November 17, 2019
Study Completion
November 17, 2019
Last Updated
February 27, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share